Metropolitan Life Insurance CO Arcturus Therapeutics Holdings Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Mar 30, 2023	SELL	$17.64 - $39.57 $86,700 - $194,486	-4,915 Reduced 77.9%	1,394 $37,000
Q1 2022 May 12, 2022	SELL	$17.64 - $39.57 $86,700 - $194,486	-4,915 Reduced 77.9%	1,394 $38,000
Q4 2021 Jun 21, 2023	BUY	$34.2 - $47.56 $168,093 - $233,757	4,915 Added 352.58%	6,309 $233,000
Q3 2021 Jun 21, 2023	BUY	$27.88 - $58.25 $137,030 - $286,298	4,915 Added 352.58%	6,309 $301,000
Q3 2021 Mar 30, 2023	BUY	$27.88 - $58.25 $1,728 - $3,611	62 Added 0.99%	6,309 $301,000
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $1,728 - $3,611	62 Added 0.99%	6,309 $301,000
Q2 2021 Jun 21, 2023	BUY	$25.79 - $42.11 $125,158 - $204,359	4,853 Added 348.13%	6,247 $211,000
Q2 2021 Aug 16, 2021	BUY	$25.79 - $42.11 $160,955 - $262,808	6,241 Added 104016.67%	6,247 $211,000
Q1 2021 Jun 26, 2023	BUY	$38.75 - $86.92 $188,053 - $421,822	4,853 Added 348.13%	6,247 $258 Million
Q1 2021 May 14, 2021	SELL	$38.75 - $86.92 $241,838 - $542,467	-6,241 Reduced 99.9%	6 $258,000
Q4 2020 Jun 22, 2023	BUY	$34.61 - $123.66 $167,962 - $600,121	4,853 Added 348.13%	6,247 $270,000
Q4 2020 Mar 30, 2023	BUY	$34.61 - $123.66 $52,503 - $187,592	1,517 Added 32.07%	6,247 $270,000
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $52,503 - $187,592	1,517 Added 32.07%	6,247 $271,000
Q3 2020 Jun 26, 2023	BUY	$37.49 - $63.19 $125,066 - $210,801	3,336 Added 239.31%	4,730 $202,000
Q3 2020 Mar 30, 2023	BUY	$37.49 - $63.19 $20,844 - $35,133	556 Added 13.32%	4,730 $202,000
Q3 2020 Nov 13, 2020	BUY	$37.49 - $63.19 $20,844 - $35,133	556 Added 13.32%	4,730 $203,000
Q2 2020 Jun 26, 2023	BUY	$12.66 - $58.27 $35,194 - $161,990	2,780 Added 199.43%	4,174 $195,000
Q2 2020 Mar 30, 2023	BUY	$12.66 - $58.27 $35,194 - $161,990	2,780 Added 199.43%	4,174 $195,000
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $52,842 - $243,218	4,174 New	4,174 $195,000

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

Federated Hermes, Inc. Pittsburgh, PA

4.69M
Shares

$80.1 Million
0.25% of portfolio
Black Rock Inc. New York, NY

2.65M
Shares

$45.2 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

2.32M
Shares

$39.5 Million
0.62% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.28M
Shares

$38.8 Million
0.04% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.1M
Shares

$35.9 Million
0.46% of portfolio

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $454M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account